Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Carde

Showing results (51-60 of 129) with videos related to

Pageof 13
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 1, 1986
Prognostic factors in non-Hodgkin's lymphomaM Tubiana, P Carde, J M Burgers, et al.
Bulletin Du Cancer|January 1, 1988
Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicityM Ghosn, P Carde, B Leclerq, et al.
Bulletin Du Cancer|January 1, 1985
[Chemotherapy by ambulatory continuous infusion using a portable pump: a feasibility trial]M Benahmed, P Carde, A Laplanche, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1996
Sjögren's syndrome with acute renal failure caused by renal pseudolymphomaP Cacoub, C Ginsburg, Z Tazi, et al.
American Journal of Hematology|August 1, 1991
Therapeutic implications and sites of relapse predicted by elevated posttherapy erythrocyte sedimentation rate in early stage Hodgkin diseaseS Friedman, M Henry-Amar, J M Cosset, et al.
Annales De Gastroenterologie Et D'Hepatologie|February 1, 1985
[Treatment of hepatic metastases with unknown primary cancer]G Piot, J P Droz, P Rougier, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1988
[Cutaneomucous adverse effects of continuous infusion of 5-fluorouracil: 12 cases]J C Guillaume, E Carp, P Rougier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Evolution of erythrocyte sedimentation rate as predictor of early relapse in posttherapy early-stage Hodgkin's diseaseS Friedman, M Henry-Amar, J M Cosset, et al.
Annals of the New York Academy of Sciences|January 1, 1991
Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferationA E Bogden, P Carde, E D de Paillette, et al.
Hematological Oncology|January 1, 1984
The prognostic significance of large mediastinal masses in the treatment of Hodgkin's disease. The experience of the Institut Gustave-RoussyJ M Cosset, M Henry-Amar, P Carde, et al.
Pageof 13

Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
International Journal of Radiation Oncology, Biology, Physics|April 1, 1986
Prognostic factors in non-Hodgkin's lymphomaM Tubiana, P Carde, J M Burgers, et al.
Bulletin Du Cancer|January 1, 1988
Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicityM Ghosn, P Carde, B Leclerq, et al.
Bulletin Du Cancer|January 1, 1985
[Chemotherapy by ambulatory continuous infusion using a portable pump: a feasibility trial]M Benahmed, P Carde, A Laplanche, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1996
Sjögren's syndrome with acute renal failure caused by renal pseudolymphomaP Cacoub, C Ginsburg, Z Tazi, et al.
American Journal of Hematology|August 1, 1991
Therapeutic implications and sites of relapse predicted by elevated posttherapy erythrocyte sedimentation rate in early stage Hodgkin diseaseS Friedman, M Henry-Amar, J M Cosset, et al.
Annales De Gastroenterologie Et D'Hepatologie|February 1, 1985
[Treatment of hepatic metastases with unknown primary cancer]G Piot, J P Droz, P Rougier, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1988
[Cutaneomucous adverse effects of continuous infusion of 5-fluorouracil: 12 cases]J C Guillaume, E Carp, P Rougier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Evolution of erythrocyte sedimentation rate as predictor of early relapse in posttherapy early-stage Hodgkin's diseaseS Friedman, M Henry-Amar, J M Cosset, et al.
Annals of the New York Academy of Sciences|January 1, 1991
Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferationA E Bogden, P Carde, E D de Paillette, et al.
Hematological Oncology|January 1, 1984
The prognostic significance of large mediastinal masses in the treatment of Hodgkin's disease. The experience of the Institut Gustave-RoussyJ M Cosset, M Henry-Amar, P Carde, et al.
Pageof 13